Mitchell Kaye is listed as an executive officer on 6 SEC Form D filings by 2 issuers between Sep 2016 and Jan 2019: BIOTECHNOLOGY VALUE FUND L P (San Francisco, CA — pooled investment fund — 2016–2019; $1.55B reported sold to 29 investors) and BIOTECHNOLOGY VALUE FUND II LP (San Francisco, CA — pooled investment fund — 2016–2019; $1.41B reported sold to 123 investors).
What this means 2 separate companies raised money with this person listed as executive officer, over about 3 years. Across those companies the filings report $2.96B sold in total.
Listed alongside BVF Inc. (6 shared filings, management entity), BVF Partners, L.P. (6 shared filings, management entity), Mark N. Lampert (6 shared filings), Matthew D. Perry (6 shared filings) and James Kratky (4 shared filings).
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Mitchell. Each name links to their own page.
All 2 issuers belong to the sponsor group Biotechnology (2 issuers, $2.96B reported sold, 2009–2025).
What this means A sponsor group is one team that sets up a new company for each deal. Biotechnology has 2 companies on file and $2.96B reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 5 bankruptcy cases matching the name listed in Key records below.
What this means 5 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 6 public filings for Mitchell Kaye and found 6 differences, 2 worth asking the sponsor about: Mitchell Kaye is no longer listed on the Jan 10, 2020 amendment; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.